Current status of countermeasures for infectious diseases and resistant microbes in the field of urology

International Journal of Urology : Official Journal of the Japanese Urological Association
Hiroyuki KitanoAkio Matsubara

Abstract

A worldwide increase in antimicrobial-resistant microbes due to the improper use of antimicrobial agents, along with a lack of progress in developing new antimicrobials, is becoming a societal problem. Although carbapenem-resistant Enterobacteriaceae, which are resistant to carbapenem antimicrobials, first appeared in 1993, treatment options remain limited. Mechanisms behind antimicrobial resistance involve changes to microbial outer membranes, drug efflux pump abnormalities, β-lactamase production and the creation of biofilms around cell bodies. Genetic information related to these forms of antimicrobial resistance exists on chromosomes and plasmids, and when located on the latter can easily be transmitted to other strains, no matter the species, which creates a risk of antimicrobial resistance spreading exceptionally rapidly. To prevent the spread of antimicrobial resistance, the World Health Organization in 2015 published an action plan on antimicrobial resistance, based on which World Health Organization member countries have laid out specific policies and targets. Urinary tract infections are a type of healthcare-associated infection, and the sexually transmitted disease pathogen, Neisseria gonorrhoeae, has been included i...Continue Reading

References

Apr 1, 1979·The Journal of Infectious Diseases·J G TullyR P Wenzel
Feb 1, 1981·Journal of Bacteriology·J E Heckels
Feb 1, 1996·Journal of Clinical Microbiology·J S JensenK Lind
Sep 1, 2000·Life Sciences·T K AuP C Leung
May 15, 2003·The Journal of Antimicrobial Chemotherapy·Claudia ThomasThomas V Riley
Jun 20, 2003·European Urology·Peter SchneedeUNKNOWN Urinary Tract Infection Working Group of the Health Care Office of the European Association of Urology
Aug 7, 2003·Sexually Transmitted Infections·L FalkJ S Jensen
Nov 9, 2006·Sexually Transmitted Infections·Berit AndersenJørgen Skov Jensen
Apr 28, 2007·American Journal of Public Health·Lisa E ManhartPatricia A Totten
Jul 17, 2007·Clinical Microbiology Reviews·Anne Marie Queenan, Karen Bush
Nov 4, 2008·PloS One·Catriona S BradshawChristopher K Fairley
Mar 17, 2009·Expert Opinion on Pharmacotherapy·Pennan M Barry, Jeffrey D Klausner
May 15, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jørgen Skov Jensen
Jul 27, 2010·Sexually Transmitted Infections·David A Lewis
Oct 15, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Pippa OakeshottJorgen S Jensen
Nov 3, 2010·Antimicrobial Agents and Chemotherapy·David M LivermoreNeil Woodford
Jan 5, 2011·Emerging Infectious Diseases·Makoto OhnishiJo Kitawaki
Mar 3, 2011·Current Infectious Disease Reports·Robert D KirkcaldyDeborah Dowell
Jul 8, 2011·Clinical Microbiology Reviews·David Taylor-Robinson, Jørgen Skov Jensen
Mar 1, 2012·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Shin ItoTakashi Deguchi
Feb 14, 2013·Sexually Transmitted Diseases·Catherine Lindsey SatterwhiteHillard Weinstock
Apr 27, 2013·The Journal of Antimicrobial Chemotherapy·Abhishek DeshpandeCurtis J Donskey
Jun 12, 2013·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Satoshi TakahashiTetsuro Matsumoto
Aug 24, 2013·The Lancet Infectious Diseases·L Silvia Munoz-PriceJohn P Quinn
Sep 21, 2013·International Journal of STD & AIDS·Deborah L CouldwellGwendolyn L Gilbert
Dec 11, 2013·The Journal of Antimicrobial Chemotherapy·Claudia Slimings, Thomas V Riley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Related Papers

JPMA. the Journal of the Pakistan Medical Association
Afia Zafar, Kauser Jabeen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Sarah Kidd, Kimberly A Workowski
Critical Reviews in Microbiology
Colin P ChurchwardLori A S Snyder
© 2021 Meta ULC. All rights reserved